Gary W Pace, Director, on July 14, 2026, executed a purchase for 687,285 shares in Cardiff Oncology (CRDF) for $1,000,000. Following the Form 4 filing with the SEC, Pace has control over a total of 2,043,661 common shares of the company, with 2,043,661 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1213037/000119312526306083/xslF345X05/ownership.xml